State Street SPDR S&P Pharmaceuticals ETF (XPH) Dividend Yield, History & Forecast

State Street SPDR S&P Pharmaceuticals ETF (XPH) is an exchange-traded fund (ETF) listed on the New York Stock Exchange Arca. It pays a current dividend yield of 0.50% ($0.34 per share annually (TTM)). The most recent ex-dividend date was June 22, 2026, with payment scheduled for June 24, 2026. market capitalization is approximately $272M. Review XPH dividend history on this scorecard, compare peers in the Compare Dividend Returns tool, or project income with the dividend calculator.

XPH fund composition

XPH holds 63 positions, with 27.5% of assets in its ten largest. It charges an expense ratio of 0.35%, and manages $580.2M.

Top 10 holdings

HoldingWeight
AMLXAMYLYX PHARMACEUTICALS INC3.83%
CRNXCRINETICS PHARMACEUTICALS IN3.60%
MBXMBX BIOSCIENCES INC2.94%
ATAIATAIBECKLEY INC2.91%
OMEROMEROS CORP2.77%
DFTXDEFINIUM THERAPEUTICS INC2.50%
ELVNENLIVEN THERAPEUTICS INC2.39%
NUVBNUVATION BIO INC2.26%
ETONETON PHARMACEUTICALS INC2.19%
CORTCORCEPT THERAPEUTICS INC2.11%

Sector allocation

Healthcare100.0%Cash & Others0.1%

Frequently Asked Questions about State Street SPDR S&P Pharmaceuticals ETF (XPH)

What is State Street SPDR S&P Pharmaceuticals ETF's dividend yield?
State Street SPDR S&P Pharmaceuticals ETF (XPH) pays a current trailing twelve-month dividend yield of 0.50%, which works out to $0.34 per share annually based on the most recent payout schedule.
When does State Street SPDR S&P Pharmaceuticals ETF pay distributions?
The most recent ex-dividend date was June 22, 2026. The next scheduled dividend payment date is June 24, 2026.
What does State Street SPDR S&P Pharmaceuticals ETF invest in?
SPDR Series Trust - SPDR S&P Pharmaceuticals ETF is an exchange traded fund launched by State Street Global Advisors, Inc. It is managed by SSGA Funds Management, Inc. It invests in public equity markets of the United States. The fund invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the S&P Pharmaceuticals Select Industry Index, by using representative sampling technique. SPDR Series Trust...